Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 9787

1.

Febuxostat for the treatment of hyperuricaemia in gout.

Robinson PC, Dalbeth N.

Expert Opin Pharmacother. 2018 Jul 19:1-11. doi: 10.1080/14656566.2018.1498842. [Epub ahead of print]

PMID:
30024787
2.

Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice.

Dolati K, Rakhshandeh H, Golestani M, Forouzanfar F, Sadeghnia R, Sadeghnia HR.

Prev Nutr Food Sci. 2018 Jun;23(2):127-133. doi: 10.3746/pnf.2018.23.2.127. Epub 2018 Jun 30.

PMID:
30018891
3.

Gout and the risk of incident atrial fibrillation in older adults: a study of US Medicare data.

Singh JA, Cleveland JD.

RMD Open. 2018 Jul 13;4(2):e000712. doi: 10.1136/rmdopen-2018-000712. eCollection 2018.

PMID:
30018808
4.

Neuroprotective Drugs in Infants With Severe Congenital Heart Disease: A Systematic Review.

Stegeman R, Lamur KD, van den Hoogen A, Breur JMPJ, Groenendaal F, Jansen NJG, Benders MJNL.

Front Neurol. 2018 Jul 3;9:521. doi: 10.3389/fneur.2018.00521. eCollection 2018.

5.

Drug reaction with eosinophilia and systemic symptoms caused by spironolactone: Case report.

Fernandes RA, Regateiro FS, Faria E, Martinho A, Gonçalo M, Todo-Bom A.

Contact Dermatitis. 2018 Jul 16. doi: 10.1111/cod.13073. [Epub ahead of print] No abstract available.

PMID:
30009386
6.

Bone mineral density and serum osteocalcin levels in patients with gout.

Dogru A, Balkarli A, Karatay CC, Cobankara V, Sahin M.

Acta Clin Belg. 2018 Jul 13:1-6. doi: 10.1080/17843286.2018.1495389. [Epub ahead of print]

PMID:
30004299
7.

Xanthine calculi in a patient with Lesch-Nyhan syndrome and factor V Leiden treated with allopurinol: case report.

Shields LBE, Peppas DS, Rosenberg E.

BMC Pediatr. 2018 Jul 12;18(1):231. doi: 10.1186/s12887-018-1197-5.

8.

Allopurinol.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

9.

A meta-analysis of the efficacy of allopurinol in reducing the incidence of myocardial infarction following coronary artery bypass grafting.

Singh TP, Skalina T, Nour D, Murali A, Morrison S, Moxon JV, Golledge J.

BMC Cardiovasc Disord. 2018 Jul 11;18(1):143. doi: 10.1186/s12872-018-0881-6.

10.
11.

Effect of Uric Acid Control on Serum Creatinine.

Yamamoto T, Xie J, Li Z, Field C, Block C, Taylor T.

J Clin Rheumatol. 2018 Jun 29. doi: 10.1097/RHU.0000000000000850. [Epub ahead of print]

PMID:
29965854
12.

[A rare case of hepatotoxicity in geriatrics].

El Kahi C, Martinet V, Praet JP, Pepersack T.

Rev Med Brux. 2018;39(3):164-165. doi: 10.30637/2018.17-018. French.

PMID:
29964389
13.

Incidence of Stevens-Johnson syndrome following combination drug use of allopurinol, carbamazepine and phenytoin in Taiwan: A case-control study.

Syu FK, Pan HY, Chuang PC, Huang YS, Cheng CY, Cheng FJ.

J Dermatol. 2018 Jul 2. doi: 10.1111/1346-8138.14528. [Epub ahead of print]

PMID:
29963717
14.

Examining the use of allopurinol: Perspectives from recent drug injury relief applications.

Huang CH, Chu MP, Chen WW.

J Formos Med Assoc. 2018 Jun 22. pii: S0929-6646(17)30905-1. doi: 10.1016/j.jfma.2018.06.006. [Epub ahead of print]

15.

Uric acid and progression of chronic kidney disease.

Weaver DJ Jr.

Pediatr Nephrol. 2018 Jun 21. doi: 10.1007/s00467-018-3979-2. [Epub ahead of print]

PMID:
29931555
16.

Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.

Graham GG, Stocker SL, Kannangara DRW, Day RO.

Curr Rheumatol Rep. 2018 Jun 21;20(8):47. doi: 10.1007/s11926-018-0760-2. Review.

PMID:
29931553
17.

Treatment of acquired reactive perforating dermatosis - a systematic review.

Lukács J, Schliemann S, Elsner P.

J Dtsch Dermatol Ges. 2018 Jul;16(7):825-842. doi: 10.1111/ddg.13561. Epub 2018 Jun 21. Review.

PMID:
29927512
18.

Genetic markers of severe cutaneous adverse reactions.

Jung JW, Kim JY, Park IW, Choi BW, Kang HR.

Korean J Intern Med. 2018 Jun 22. doi: 10.3904/kjim.2018.126. [Epub ahead of print]

19.

Graphene and graphene oxide induce ROS production in human HaCaT skin keratinocytes: the role of xanthine oxidase and NADH dehydrogenase.

Pelin M, Fusco L, Martín C, Sosa S, Frontiñán-Rubio J, González-Domínguez JM, Durán-Prado M, Vázquez E, Prato M, Tubaro A.

Nanoscale. 2018 Jul 5;10(25):11820-11830. doi: 10.1039/c8nr02933d.

PMID:
29920573
20.

The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.

Sakuma M, Toyoda S, Arikawa T, Koyabu Y, Kato T, Adachi T, Suwa H, Narita JI, Anraku K, Ishimura K, Yamauchi F, Sato Y, Inoue T; For Excited UA study Investigators.

Clin Exp Nephrol. 2018 Jun 18. doi: 10.1007/s10157-018-1599-6. [Epub ahead of print]

PMID:
29916098

Supplemental Content

Loading ...
Support Center